Načítá se...
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: Does the increased risk ever disappear? A randomized trial
BACKGROUND: Estrogen-plus-progestin therapy increases the risk of coronary heart disease (CHD) in postmenopausal women. However, this increased risk might be limited to the first years of use and to women who start therapy late in menopause. OBJECTIVE: To estimate the effect of continuous estrogen-p...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2936769/ https://ncbi.nlm.nih.gov/pubmed/20157135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1059/0003-4819-152-4-201002160-00005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|